Association study of genetic markers of schizophrenia and its cognitive endophenotypes
- 50 Downloads
A replicative analysis of associations of 15 SNPs located in the regions of 11 genes (TCF4, VRK2, NOTCH4, ZNF804A, AGBL1, RELN, ZFP64P1, KCNB2, CSMD1, CPVL, NRIP1) and three intergenic regions (SLCO6A1/LINCOO491, LOC105376248/LOC105376249, SPA17/NRGN) with schizophrenia was conducted in the Russian population of the Siberian region. These SNPs were previously identified in genome-wide association studies (GWAS) of schizophrenia and cognitive abnormalities. The present study confirmed associations of KCNB2 rs2247572, CSMD1 rs2616984, and intergenic rs12807809 located in SPA17/NRGN with schizophrenia. It was established that the frequency of the CSMD1 rs2616984 G/G genotype was higher in patients compared to the control group (OR = 1.73; CI: 1.14–2.62; р = 0.0337). The frequencies of the KCNB2 rs2247572 TT genotype (OR = 0.41; CI: 0.20–0.87; р = 0.0485) and intergenic rs12807809 CT genotype located in SPA17/NRGN (OR = 0.70; CI: 0.53–0.94; р = 0.0464) were significantly decreased in patients compared to the control group.
Keywordsschizophrenia cognitive endophenotypes association study multifactorial diseases Russian population
Unable to display preview. Download preview PDF.
- 1.http://www.ncbi.nlm.nih.gov/pubmed.Google Scholar
- 2.Mosolov, S.N., Some current theoretical problems of diagnostics, classification, neurobiology and treatment of schizophrenia: a comparison of foreign and domestic approaches, Korsakov J. Neurol. Psychiatry, 2010, vol. 6, pp. 4–11.Google Scholar
- 3.The World Health Report 2001—Mental Health: New Understanding, New Hope. http://www.who.int/whr/2001/en/.Google Scholar
- 6.http://www.ebi.ac.uk/gwas.Google Scholar
- 9.Alfimova, M.V., Abramova, L.I., Aksenova, E.V., et al., Association between polymorphism of the neuregulin gene (NRG1) and cognitive functions in schizophrenia patients and healthy subjects, Korsakov J. Neurol. Psychiatry, 2011, no. 6, pp. 53–57.Google Scholar
- 10.Fedorenko, O.Yu., Rudikov, E.V., Gavrilova, V.A., et al., Association of (N251S)-PIP5K2A with schizophrenic disorders: a study of the Russian population of Siberia, Korsakov J. Neurol. Psychiatry, 2013, vol. 113, no. 5, pp. 58–61.Google Scholar
- 18.Weir, B.S., Genetic Data Analysis: Method for Discrete Population Genetic Data, Sunderland: Sinauer Associates, 1990.Google Scholar
- 20.Sherva, R., Tripodis, Y., Bennett, D.A., et al., Genome-wide association study of the rate of cognitive decline in Alzheimer’s disease, AlzheimersDement., 2014, vol. 10, pp. 45–52.Google Scholar
- 21.Xu, W., Cohen-Woods, S., Chen, Q., et al., Genomewide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1, BMC Med. Genet., 2014, vol. 15, no. 2. doi 10.1186/1471-2350-15-2Google Scholar
- 23.Koiliari, E., Roussos, P., Pasparakis, E., et al., The CSMD1 genome-wide associated schizophrenia risk variant rs10503253 affects general cognitive ability and executive function in healthy males, Schizophr. Res., 2014, vol. 154, nos. 1–3, pp. 42–47. doi 10.1016/j.schres.2014.02.017CrossRefPubMedGoogle Scholar
- 26.Shcherbakova, I.V., Activation of innate immunity in schizophrenia, Korsakov J. Neurol. Psychiatry, 2006, vol. 10, pp. 79–82.Google Scholar